Get notified when CYCN files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — Cyclerion's financial statements and auditor's report include substantial doubt about its ability to continue as a going concern, and management states cash will not be sufficient to fund operations until the merger completes.
- Sole Employee (new) — The company has only one employee, creating extreme key-person risk.
- Delisted (new) — The company previously faced delisting and could face it again if the stock price falls below $1.00.
- Shell Company (new) — The combined company will be treated as a former shell company, limiting its ability to use Form S-3 for 12 months and restricting resales under Rule 144 for one year.
- Dilution (new) — Cyclerion shareholders will be diluted to about 1.1% ownership after the merger, while Korsana securityholders will own about 98.9%.
Cyclerion to merge with Korsana in reverse merger; Korsana holders to own 98.9% of combined company
Filed July 24, 2026 · ~2 min read
Key Changes
-
high
Cyclerion and Korsana propose a merger where Korsana becomes a wholly owned subsidiary and Cyclerion renames to Korsana Biosciences, Inc.
The Offering verify on EDGAR → -
high
Immediately after the merger, Cyclerion securityholders are expected to own approximately 1.1% of the combined company, while former Korsana securityholders own approximately 98.9%.
Prospectus Summary verify on EDGAR → -
high
Korsana has secured a $380 million pre-closing financing from institutional and accredited investors, contingent on the merger closing.
Prospectus Summary verify on EDGAR →
5 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ORCL 10-Q) is open in full — no account needed.
Partner
Trade CYCN commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify